Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03748342 · ClinicalTrials.gov registry record · NA
Second Generation LMA Versus Endotracheal Tube in Obese Patients
A NA study of Obese and Endotracheal Tube, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 2
- Study locations
NCT03748342: Completed NA study of Obese and Endotracheal Tube, sponsored by University of Texas Southwestern Medical Center.
NCT03748342 is a NA study of Obese and Endotracheal Tube that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 97 participants, below the 208-participant average among 27 other Obese trials with a reported enrollment target (53% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03748342, a NA study of Obese and Endotracheal Tube, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 2
- Study locations
Study Summary
This prospective, randomized, comparative study is intended to enroll a total of 148 patients with a BMI 30-49.9 kg/m2 undergoing surgery at Parkland Hospital. The efficacy and performance of a second-generation LMA will be compared to endotracheal intubation. A standardized anesthetic protocol that is usual and customary for the type of operation the patient is having will be provided to the anesthesia teams of enrolled subjects. The remainder of the anesthetic care of the subject will not deviate from the standard of care.
Primary Outcome
Patients in the 2 groups will be assessed for postoperative hypoxia (1 or more episodes) in the PACU using a visual analog scale.
Conditions Studied
Interventions
- DEVICE Second-Generation Laryngeal Mask Airway
Study Locations (2)
Texas
- Parkland Health & Hospital System - Dallas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2019-06-27 |
| Est. Completion | 2025-02-03 |
| Phase | NA |
What the finished NCT03748342 record still lists
NCT03748342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 208-participant average among 27 other Obese trials with a reported enrollment target (53% lower).
The record links to 3 conditions, with Obese appearing as the primary indexed condition, and to 1 intervention - of which Second-Generation Laryngeal Mask Airway is the first listed.
NCT03748342 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03748342 about?
NCT03748342 is a clinical study titled "Second Generation LMA Versus Endotracheal Tube in Obese Patients". This prospective, randomized, comparative study is intended to enroll a total of 148 patients with a BMI 30-49.9 kg/m2 undergoing surgery at Parkland Hospital. The efficacy and performance of a second-generation LMA will be compared to endotracheal intubation. A standardized anesthetic protocol that...
What is the current status of trial NCT03748342?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2019-06-27. Estimated completion is 2025-02-03.
What conditions does trial NCT03748342 study?
This clinical trial studies the following conditions: Obese, Endotracheal Tube, Laryngeal Mask Airway.
What interventions are being tested in trial NCT03748342?
The interventions under investigation include: Second-Generation Laryngeal Mask Airway (DEVICE).
Who is sponsoring clinical trial NCT03748342?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03748342 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obese
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03748342's enrollment target sits among peer trials
97 17th of 27 higher than 11 of 27 other Obese trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obese trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men
ACTIVE NOT RECRUITING · NA
-
Brain Fuel - Morning Nutrition and Cognitive Function
ACTIVE NOT RECRUITING · NA
-
The Expecting Study
ACTIVE NOT RECRUITING · NA
-
Olive Oil Polyphenols and Cardiovascular Health Biomarkers
ACTIVE NOT RECRUITING · NA
-
mFit: The Mobile Fitness Project
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI